The FDA has approved narsoplimab (Yartemlea) as the first treatment for hematopoietic stem cell transplant (HSCT)-associated ...

Cancer has a talent for hiding in plain sight, cloaking itself in sugary molecules that convince the immune system to stand ...

Summary • Omeros Corporation’s stock jumped 72.1% to $15.06 following FDA approval of Yartemlea, its therapy for TA-TMA.• Yartemlea is the first therapy targeting hematopoietic stem cell ...

Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® ...

Trapped in a hell he helped make, a lone hacker aboard a space station far from home sneaks and fights his way through horrible mutants and killer robots in order to take down the monstrous artificial ...

The new grading structure under the Competency-Based Education (CBE) system is going to reshape how learners transitioning to Senior School will be assessed and placed. The system, built on cumulative ...

Scientists have identified a gut microbe molecule, trimethylamine (TMA), that shows promise in controlling blood sugar and combating insulin resistance. This discovery offers a new direction for ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Generative AI is infiltrating everything you do online, including how you find information. If you're bored with traditional search, check out the top AI search engines we've tried.